C73 - Malignant neoplasm of thyroid gland
ICD-10: | C73 |
Short Description: | Malignant neoplasm of thyroid gland |
Long Description: | Malignant neoplasm of thyroid gland |
Status: | Valid for Submission |
Version: | ICD-10-CM 2023 |
Code Classification: |
C73 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of thyroid gland. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic thyroglossal duct or Neoplasm, neoplastic thyroid (gland) .
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Anaplastic thyroid carcinoma
- Carcinoma of thyroid
- Diffuse sclerosing papillary thyroid carcinoma
- Familial nonmedullary thyroid carcinoma
- Familial papillary thyroid carcinoma with renal papillary neoplasia syndrome
- Follicular neoplasm of thyroid
- Follicular thyroid carcinoma
- Hurthle cell carcinoma of thyroid
- Local recurrence of malignant tumor of thyroid gland
- Malignant tumor of thyroid gland
- Medullary thyroid carcinoma
- Metastasis from malignant tumor of thyroid
- Mixed follicular and papillary thyroid carcinoma
- Neoplasm of thyroglossal duct
- Oxyphilic adenocarcinoma
- Papillary thyroid carcinoma
- Papillary thyroid carcinoma with renal papillary neoplasia
- Parafollicular cell carcinoma
- pN1a category
- pN1a: Metastasis to level VI
- pN1b category
- pN1b: Metastasis to unilateral, bilateral, or contralateral cervical or superior mediastinal lymph nodes
- Primary differentiated carcinoma of thyroid gland
- Primary malignant neoplasm of thyroglossal duct
- Primary malignant neoplasm of thyroid gland
- Primary poorly differentiated carcinoma of thyroid gland
- Primary undifferentiated carcinoma of thyroid gland
- pT1: Tumor 2 cm or less in greatest dimension limited to the thyroid
- pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid
- pT3: Tumor more than 4 cm in greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension
- pT4a: Intrathyroidal anaplastic carcinoma - surgically resectable
- pT4a: Tumor of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve
- pT4b: Extrathyroidal anaplastic carcinoma - surgically unresectable
- pT4b: Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels
- Secondary malignant neoplasm of lymph nodes of neck
- Secondary malignant neoplasm of lymph nodes of neck from thyroid
- T1: Tumor size < 1 cm, limited to thyroid
- T2: Tumor > 1 cm but < 4 cm, limited to thyroid
- T3: Thyroid tumor > 4 cm, limited to thyroid
- T4: Thyroid tumor of any size extending beyond the thyroid capsule
- Thyroid cancer metastatic to bone
- Thyroid TNM finding
- Thyroid TNM finding
- Thyroid TNM finding
- Thyroid TNM finding
- Thyroid TNM finding
- Thyroid TNM finding
- Thyroid TNM finding
- Thyroid TNM finding
- Thyroid TNM finding
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to this diagnosis code:
Use Additional Code
Use Additional CodeThe “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
- code to identify any functional activity
Index to Diseases and Injuries References
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:
- - Adenocarcinoma - See Also: Neoplasm, malignant, by site;
- - follicular
- - with papillary - C73
- - moderately differentiated - C73
- - trabecular - C73
- - unspecified site - C73
- - well differentiated - C73
- - Hurthle cell - C73
- - nonencapsulated sclerosing - C73
- - papillary
- - with follicular - C73
- - follicular variant - C73
- - follicular
- - Carcinoma (malignant) - See Also: Neoplasm, by site, malignant;
- - C cell
- - unspecified site - C73
- - follicular
- - with papillary (mixed) - C73
- - moderately differentiated - C73
- - pure follicle - C73
- - trabecular - C73
- - unspecified site - C73
- - well differentiated - C73
- - Hurthle cell - C73
- - medullary
- - with
- - amyloid stroma
- - unspecified site - C73
- - amyloid stroma
- - with
- - nonencapsulated sclerosing - C73
- - papillary
- - with follicular (mixed) - C73
- - follicular variant - C73
- - parafollicular cell
- - unspecified site - C73
- - solid
- - with amyloid stroma
- - unspecified site - C73
- - with amyloid stroma
- - C cell
- - Hurthle cell
- - adenocarcinoma - C73
- - carcinoma - C73
- - Tumor - See Also: Neoplasm, unspecified behavior, by site;
- - Hurthle cell (benign) - D34
- - malignant - C73
- - nonencapsulated sclerosing - C73
- - Hurthle cell (benign) - D34
- - Wuchernde Struma Langhans - C73
Convert to ICD-9 Code
Source ICD-10 Code | Target ICD-9 Code | |
---|---|---|
C73 | 193 - Malign neopl thyroid |
Table of Neoplasms
This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
Neoplasm, neoplastic | Malignant Primary |
Malignant Secondary |
CaInSitu | Benign | Uncertain Behavior |
Unspecified Behavior |
---|---|---|---|---|---|---|
»Neoplasm, neoplastic »thyroglossal duct | C73 | C79.89 | D09.3 | D34 | D44.0 | D49.7 |
»Neoplasm, neoplastic »thyroid (gland) | C73 | C79.89 | D09.3 | D34 | D44.0 | D49.7 |
Patient Education
Thyroid Cancer
Your thyroid is a butterfly-shaped gland in your neck, just above your collarbone. It makes hormones that help the body work normally. There are several types of cancer of the thyroid gland. You are at greater risk if you:
- Are between ages 25 and 65
- Are a woman
- Are Asian
- Have a family member who has had thyroid disease
- Have had radiation treatments to your head or neck
You should see a doctor if you have a lump or swelling in your neck. Doctors use a physical exam, thyroid tests, other blood and imaging tests, and a biopsy to diagnose thyroid cancer. Treatment depends on the type of cancer you have and how far the cancer has spread. Many patients receive a combination of treatments. They may include surgery, radioactive iodine, hormone treatment, radiation therapy, chemotherapy, or targeted therapy. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Thyroid Cancer—Patient Version
Learn about thyroid cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.[Learn More in MedlinePlus]
Code History
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)